[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
R Laforest, SE Lapi, R Oyama, R Bose… - Molecular imaging and …, 2016 - Springer
Purpose The purpose of the present study is to evaluate safety, human radiation dosimetry,
and optimal imaging time of [ 89 Zr]trastuzumab in patients with HER2-positive breast cancer. …
and optimal imaging time of [ 89 Zr]trastuzumab in patients with HER2-positive breast cancer. …
First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging
R Laforest, A Ghai, TJ Fraum, R Oyama… - Journal of Nuclear …, 2023 - Soc Nuclear Med
There remains an unmet need for molecularly targeted imaging agents for multiple myeloma
(MM). The integrin very late antigen 4 (VLA4), is differentially expressed in malignant MM …
(MM). The integrin very late antigen 4 (VLA4), is differentially expressed in malignant MM …
Radiopharmaceutical quality control considerations for accelerator-produced actinium therapies
Background: Alpha-particle-emitting radiotherapies are of great interest for the treatment of
disseminated cancer. Actinium-225 ( 225 Ac) produces four α-particles through its decay and …
disseminated cancer. Actinium-225 ( 225 Ac) produces four α-particles through its decay and …
The role of exploratory investigational new drugs for translating radiopharmaceuticals into first-in-human studies
SW Schwarz, R Oyama - Journal of Nuclear Medicine, 2015 - Soc Nuclear Med
The Food and Drug Administration has provided a mechanism to reduce time and resources
expended on new pharmaceuticals, including radiopharmaceuticals, in order to identify the …
expended on new pharmaceuticals, including radiopharmaceuticals, in order to identify the …
Radiochemistry and radiopharmacology
SW Schwarz, R Oyama… - Nuclear Medicine and …, 2016 - books.google.com
Approximately 275 different nuclei have shown no evidence of radioactive decay and hence
are considered stable regarding this type of transformation. Figure 4-1 shows the …
are considered stable regarding this type of transformation. Figure 4-1 shows the …
Weaknesses in Japan's post war politics
R Oyama, T Takeda - 2010 - eprints.lse.ac.uk
Discusses Japan’s political immobilism caused by lack of strong ministerial leadership and
failure of reform initiatives. Attributes it to the power of factions within political parties which …
failure of reform initiatives. Attributes it to the power of factions within political parties which …
Rebuilding Representative Democracy
R Oyama - 2016 - academic.oup.com
A sense of mistrust in representative democracy can be seen as a common phenomenon in
economically developed countries. The phenomenon is especially conspicuous in Japan, …
economically developed countries. The phenomenon is especially conspicuous in Japan, …
Validation of a nucleophilic synthesis platform for clinical application of [18F] fluorodopa
S Moerlein, C Bognar, G Gaehle, R Oyama, S Schwarz… - 2017 - Soc Nuclear Med
255 Objectives: 6-[ 18 F]Fluorodopa (FDOPA) is useful for PET studies of movement
disorders like Parkinson disease and oncological conditions like neuroblastoma. Fdopa is …
disorders like Parkinson disease and oncological conditions like neuroblastoma. Fdopa is …
Westminster Model under Electoral Reform New Zealand and Japan
R OYAMA - Japanese Journal of Electoral Studies, 2001 - jstage.jst.go.jp
これまで最も純粋なウェストミンスターモデルの政府をもつ国とみなされてきたニュージーランドは,
1993 年に新しい選挙制度の導入に踏み切った. ドイツ型の小選挙区比例代表併用制の採用は, …
1993 年に新しい選挙制度の導入に踏み切った. ドイツ型の小選挙区比例代表併用制の採用は, …
Regulating the French Presidential Election
R OYAMA - Japanese Journal of Electoral Studies, 1997 - jstage.jst.go.jp
Direct elections of the Presidency after the constitutional amendment of 1962 had the effects
of not only developing bipolarisation between Left and Right, but also changing …
of not only developing bipolarisation between Left and Right, but also changing …